New York City-based NYU Langone Health has gained an equity stake in 3D digital surgery company Medical iSight as part of a development deal.
The collaboration will test the company's visualization, navigation and predictive algorithms on the removal of blood clots after a stroke and blood vessel repair after an aneurysm.
"We are delighted to be working with NYU Langone Health and their world-class doctors to advance our groundbreaking interventional software and deliver on our vision to unite surgical digital information within a single cognitive platform, to make it universally accessible, thereby resulting in better patient outcomes," Medical iSight CEO Justin Hall-Tipping said in a Jan. 30 company news release.